Skip to main content
logo
Arecor Therapeutics plc (AIM:AREC)
London flag London · Delayed Price · Currency is GBP · Price in GBX
70.00
+4.00 (6.06%)
May 26, 2026, 10:18 AM GMT

Arecor Therapeutics Cash Flow Statement

Millions GBP. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
0.66-10.24-8.55-9.26-6.17
Depreciation & Amortization
0.210.350.490.340.17
Other Amortization
0.010.010.010-
Loss (Gain) From Sale of Assets
-4.98----
Stock-Based Compensation
0.320.160.640.50.48
Other Operating Activities
0.635.06-0.48-0.710.48
Change in Accounts Receivable
-0.370.38-1-0.05-1.26
Change in Inventory
--0.360.59-
Change in Accounts Payable
0.32-1.071.38-2.20.84
Change in Other Net Operating Assets
0.11-0.351.33--
Operating Cash Flow
-2.36-9.33-5.84-10.78-5.45
Capital Expenditures
-0.1-0.01-0.15-0.3-0.07
Sale of Property, Plant & Equipment
0.01-0.01--
Cash Acquisitions
---0.28-
Sale (Purchase) of Intangibles
5.19---0.05-
Investment in Securities
-3.111.646.38-8.04-
Other Investing Activities
0.470.090.280.110
Investing Cash Flow
2.461.726.52-7.99-0.07
Long-Term Debt Issued
-0.010.04-2.5
Short-Term Debt Repaid
----0.3-
Long-Term Debt Repaid
-0.09-0.09-0.2-0.17-0.11
Total Debt Repaid
-0.09-0.09-0.2-0.46-0.11
Net Debt Issued (Repaid)
-0.09-0.08-0.17-0.462.39
Issuance of Common Stock
-6.42-620
Other Financing Activities
-0.06-0.69-0.02-0.38-1.46
Financing Cash Flow
-0.155.65-0.185.1620.93
Foreign Exchange Rate Adjustments
-0.180.11-0.170.060.01
Net Cash Flow
-0.24-1.850.33-13.5515.42
Free Cash Flow
-2.46-9.34-5.99-11.08-5.52
Free Cash Flow Margin
-143.64%-568.35%-131.03%-461.05%-476.60%
Free Cash Flow Per Share
-0.06-0.28-0.20-0.38-0.24
Cash Interest Paid
0.010.020.020.030.02
Cash Income Tax Paid
-0.36---0.73-0.76
Levered Free Cash Flow
4.88-5.2-3-7.06-3.6
Unlevered Free Cash Flow
4.88-5.19-2.99-7.05-3.59
Change in Working Capital
0.06-1.042.06-1.66-0.42
Source: S&P Global Market Intelligence. Standard template. Financial Sources.